Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00787761 · OUTCOME

Number of Patients Who Experience Severe (Grade 3 or 4) Acute Graft-versus-host Disease

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer · Source last updated 2012-10-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Day 100

What was measured

number of patients who experienced post-transplant complication (GVHD) as seen by clinical evidence including but not limited to skin rash, elevated liver function tests, nausea/vomiting/diarrhea.

Analysis population: 23 patients were able to be analyzed for severe gvhd

Groups in this outcome

Severe Graft Versus Host Disease

patients receiving transplant using ATG/Bu/Flu/Cy per this protocol and who had severe graft versus host disease as a post-transplant complication

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Severe Graft Versus Host Disease23

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Severe Graft Versus Host Disease2Not reported020Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        20
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      23
    units
    Participants
description
number of patients who experienced post-transplant complication (GVHD) as seen by clinical evidence including but not limited to skin rash, elevated liver function tests, nausea/vomiting/diarrhea.
groups
  1. description
    patients receiving transplant using ATG/Bu/Flu/Cy per this protocol and who had severe graft versus host disease as a post-transplant complication
    id
    OG000
    title
    Severe Graft Versus Host Disease
param Type
NUMBER
population Description
23 patients were able to be analyzed for severe gvhd
reporting Status
POSTED
time Frame
Day 100
title
Number of Patients Who Experience Severe (Grade 3 or 4) Acute Graft-versus-host Disease
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice